{"id":2416,"date":"2021-12-27T15:49:35","date_gmt":"2021-12-27T15:49:35","guid":{"rendered":"https:\/\/www.barnaclinic.com\/blog\/ca\/?p=2416"},"modified":"2021-12-27T15:51:00","modified_gmt":"2021-12-27T15:51:00","slug":"biopsia-liquida-analisi-del-cancer","status":"publish","type":"post","link":"https:\/\/www.barnaclinic.com\/blog\/ca\/blog\/biopsia-liquida-analisi-del-cancer\/","title":{"rendered":"La bi\u00f2psia l\u00edquida demostra la seva utilitat a l&#8217;an\u00e0lisi del c\u00e0ncer"},"content":{"rendered":"<p>Un dels grans reptes en el <strong>tractament del c\u00e0ncer<\/strong> \u00e9s la seva heterogene\u00eftat. Els tumors poden presentar diferents mutacions i canviar al llarg del temps, cosa que fa que no tots els tractaments siguin efica\u00e7os o que es generin resist\u00e8ncies. Per aix\u00f2 cal fer seguiments que permetin identificar els canvis que es van produint. Tot i aix\u00f2, l&#8217;obtenci\u00f3 de les mostres necess\u00e0ries per fer aquestes an\u00e0lisis a trav\u00e9s d&#8217;una <strong>bi\u00f2psia de teixit<\/strong> no sempre \u00e9s f\u00e0cil. Per aix\u00f2, en els darrers anys, s&#8217;ha desenvolupat un nou m\u00e8tode que permeti <strong>analitzar l&#8217;ADN tumoral circulant a la sang<\/strong> per poder fer aquest <strong>seguiment i an\u00e0lisi del c\u00e0ncer<\/strong> d&#8217;una manera m\u00e9s f\u00e0cil i senzilla. \u00c9s el que es coneix com a <a href=\"https:\/\/www.barnaclinic.com\/blog\/oncologia\/ca\/biopsia-liquida\/\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>bi\u00f2psia l\u00edquida<\/strong><\/a>.<\/p>\n<p><!--more--><\/p>\n<div id=\"estoy-interesado\" class=\"destacat-site\">\n<h4 style=\"padding-left: 15px; padding-right: 15px; text-align: left;\" align=\"CENTER\"><span style=\"color: white;\">LI POT INTERESSAR&#8230;<\/span><\/h4>\n<ul>\n<li>\n<h4 class=\"f\"><a href=\"https:\/\/www.barnaclinic.com\/blog\/oncologia\/ca\/biopsia-liquida\/\" target=\"_blank\" rel=\"noopener noreferrer\">La bi\u00f2psia l\u00edquida, diagn\u00f2stic del c\u00e0ncer no invasiu, tractament personalitzat i seguiment<\/a><\/h4>\n<\/li>\n<\/ul>\n<\/div>\n<p>Els resultats preliminars de l&#8217;estudi CLIMB360, desenvolupat pel Dr. <strong><a href=\"https:\/\/www.barnaclinic.com\/ca\/quadre-medic\/308\/aleix\">Aleix Prat<\/a><\/strong> i el Dr. <strong><a href=\"https:\/\/www.barnaclinic.com\/ca\/quadre-medic\/478\/javier\">Javier Garc\u00eda Corbacho<\/a><\/strong>, professionals ambd\u00f3s del Grup Hospital Cl\u00ednic i de barnacl\u00ednic+, han demostrat que utilitzar aquesta t\u00e8cnica de la <strong>bi\u00f2psia l\u00edquida per a obtenir el perfil gen\u00f2mic prospectiu i en temps real<\/strong> dels pacients \u00e9s factible, r\u00e0pid i ajuda a <strong>identificar dianes terap\u00e8utiques<\/strong> aprovades o avaluades en assaigs cl\u00ednics. Aquests resultats <a href=\"https:\/\/www.annalsofoncology.org\/article\/S0923-7534(21)02601-6\/fulltext\">han estat publicats a <em>Annals of Oncology<\/em><\/a>, la revista de la <a href=\"https:\/\/www.esmo.org\/\">Societat Europea d&#8217;Oncologia M\u00e8dica (ESMO)<\/a>.<\/p>\n<p>Per dur a terme aquest estudi es va analitzar el perfil gen\u00e8tic de 321 pacients oncol\u00f2gics amb diferents tumors s\u00f2lids \u2013<a href=\"https:\/\/www.barnaclinic.com\/ca\/diagnostic-del-cancer\/diagnostic-cancer-de-pulmo\/\">pulmonars<\/a>, <a href=\"https:\/\/www.barnaclinic.com\/blog\/cirugia-del-pancreas\/supervivencia-en-cancer-de-pancreas\/\">pancre\u00e0tics<\/a>, <a href=\"https:\/\/www.barnaclinic.com\/ca\/diagnostic-del-cancer\/deteccio-cancer-colon-recte\/\">colorectals<\/a>, colangiocarcinoma, de mama, <a href=\"https:\/\/www.barnaclinic.com\/blog\/cirugia-de-tiroides\/cancer-de-tiroides\/\">de tiroide<\/a> i <a href=\"https:\/\/www.barnaclinic.com\/blog\/orl\/ca\/tumor-de-la-glandula-salival\/\">carcinoma de gl\u00e0ndules salivals<\/a>\u2013 mitjan\u00e7ant <strong>bi\u00f2psia l\u00edquida a la sang amb <a href=\"https:\/\/www.barnaclinic.com\/blog\/ca\/blog\/guardant-360\/\">Guardant360<\/a><\/strong>, una prova capa\u00e7 d&#8217;analitzar 74 gens mitjan\u00e7ant t\u00e8cniques de seq\u00fcenciaci\u00f3 massiva. L&#8217;estudi, que va comen\u00e7ar el setembre del 2020, va establir una <strong>seq\u00fcenciaci\u00f3 gen\u00f2mica dels tumors<\/strong> d&#8217;aquests pacients al llarg de 18 mesos. Es buscava aix\u00ed poder seleccionar la ter\u00e0pia m\u00e9s adequada segons l&#8217;evoluci\u00f3 de la malaltia en cada pacient.<\/p>\n<div id=\"estoy-interesado\" class=\"destacat-site\">\n<h4 style=\"padding-left: 15px; padding-right: 15px; text-align: left;\" align=\"CENTER\"><span style=\"color: white;\">LI POT INTERESSAR&#8230;<\/span><\/h4>\n<ul>\n<li>\n<h4 class=\"f\"><a href=\"https:\/\/www.barnaclinic.com\/blog\/ca\/blog\/guardant-360\/\" target=\"_blank\" rel=\"noopener noreferrer\">El millor test de bi\u00f2psia l\u00edquida per a pacients amb c\u00e0ncer avan\u00e7at arriba a barnacl\u00ednic+<\/a><\/h4>\n<\/li>\n<\/ul>\n<\/div>\n<h2>La bi\u00f2psia l\u00edquida, m\u00e9s r\u00e0pida i senzilla<\/h2>\n<p>L&#8217;obtenci\u00f3 de mostres de tumors s\u00f2lids mitjan\u00e7ant una bi\u00f2psia pot ser un proc\u00e9s complex i no sempre r\u00e0pid. Els resultats d&#8217;una bi\u00f2psia tumoral poden trigar m\u00e9s d&#8217;un mes, massa temps per a molts pacients als quals pot constrenyir un canvi de ter\u00e0pia segons l&#8217;evoluci\u00f3 de la seva malaltia. A m\u00e9s, en certs <strong>tipus de c\u00e0ncer<\/strong>, com <a href=\"https:\/\/www.barnaclinic.com\/ca\/diagnostic-del-cancer\/diagnostic-cancer-de-pulmo\/\">el de pulm\u00f3<\/a>, fer una bi\u00f2psia de teixits \u00e9s molt cost\u00f3s.<\/p>\n<p>Per contra, <strong>els resultats d&#8217;una bi\u00f2psia l\u00edquida s\u00f3n molt m\u00e9s r\u00e0pids<\/strong>, i es poden obtenir en nom\u00e9s nou dies naturals. I a difer\u00e8ncia de les bi\u00f2psies tumorals, que s\u00f3n invasives i potencialment doloroses, <strong>per a la\u00a0<a href=\"https:\/\/www.barnaclinic.com\/blog\/oncologia\/ca\/biopsia-liquida\/\" target=\"_blank\" rel=\"noopener noreferrer\">bi\u00f2psia l\u00edquida<\/a> nom\u00e9s cal una extracci\u00f3 de 20 ml de sang<\/strong>. Aix\u00f2 tamb\u00e9 facilita que es puguin dur a terme de manera m\u00e9s repetida i fer un seguiment m\u00e9s prec\u00eds de l&#8217;evoluci\u00f3 del tumor alhora que no suposa una mol\u00e8stia excessiva per al pacient.<\/p>\n<blockquote>\n<h4>Els resultats d&#8217;una\u00a0<a href=\"https:\/\/www.barnaclinic.com\/blog\/oncologia\/ca\/biopsia-liquida\/\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>bi\u00f2psia l\u00edquida<\/strong><\/a> s\u00f3n molt m\u00e9s r\u00e0pids i nom\u00e9s cal una extracci\u00f3 de 20 ml de sang<\/h4>\n<\/blockquote>\n<h2>Per qu\u00e8 serveix la bi\u00f2psia l\u00edquida a la sang?<\/h2>\n<p>De vegades, quan hi ha un tumor, s&#8217;allibera material gen\u00e8tic, prote\u00efnes i c\u00e8l\u00b7lules cancer\u00edgenes al torrent sanguini. Actualment amb tan sols una extracci\u00f3 de sang es pot detectar aquest ADN circulant, c\u00e8l\u00b7lules tumorals i altres compostos propis del tumor. Les <strong>t\u00e8cniques per a la detecci\u00f3 de l&#8217;ADN circulant i de c\u00e8l\u00b7lules tumorals<\/strong> han de ser ultrasensibles, ja que aquests compostos i c\u00e8l\u00b7lules es troben en una proporci\u00f3 extremadament baixa a la sang. Les <strong>c\u00e8l\u00b7lules cancer\u00edgenes en circulaci\u00f3<\/strong> es poden establir en una altra part de l&#8217;organisme, generant una met\u00e0stasi. La <strong>detecci\u00f3 de l&#8217;ADN de les c\u00e8l\u00b7lules tumorals<\/strong> permet determinar l&#8217;evoluci\u00f3 de la malaltia i seleccionar els tractaments per tractar el tumor espec\u00edficament.<\/p>\n<hr \/>\n<p><iframe loading=\"lazy\" src=\"https:\/\/www.youtube.com\/embed\/U2TzuFWMZ_w\" width=\"750\" height=\"422\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\" data-mce-fragment=\"1\"><\/iframe><\/p>\n<hr \/>\n<h2>Com es fa la bi\u00f2psia l\u00edquida?<\/h2>\n<p>Amb el\u00a0<strong><a href=\"https:\/\/www.barnaclinic.com\/blog\/ca\/blog\/guardant-360\/\">Guardant360<\/a><\/strong>. \u00c9s una <strong>prova de bi\u00f2psia l\u00edquida<\/strong> capa\u00e7 d&#8217;analitzar 74 gens mitjan\u00e7ant t\u00e8cniques de seq\u00fcenciaci\u00f3 massiva. D&#8217;aquesta manera, s&#8217;identifiquen mutacions, c\u00f2pies g\u00e8niques, <strong>gens implicats en el desenvolupament de tumors s\u00f2lids i <a href=\"https:\/\/www.barnaclinic.com\/ca\/diagnostic-del-cancer\/estudi-genetic-risc-cancer\/\">c\u00e0ncers hereditaris<\/a><\/strong>, i inestabilitat de microsat\u00e8l\u00b7lits, que s\u00f3n seq\u00fc\u00e8ncies curtes d&#8217;ADN que no codifiquen cap gen per\u00f2 constitueixen marcadors gen\u00e8tics en alguns c\u00e0ncers. La sensibilitat de la prova \u00e9s molt elevada ja que a l&#8217;estudi es van detectar alteracions gen\u00f2miques en pr\u00e0cticament el 90% dels casos, la qual cosa obre la porta a una potencial ter\u00e0pia dirigida contra cada tipus de c\u00e0ncer.<\/p>\n<p>La <strong>bi\u00f2psia l\u00edquida<\/strong> ha de ser interpretada per seleccionar el tractament correcte. per aix\u00f2, s&#8217;han comen\u00e7at a crear grups especialistes (tumor molecular board) que revisen cada cas i emeten una recomanaci\u00f3 conjunta. L&#8217;<strong><a href=\"https:\/\/www.barnaclinic.com\/ca\/oncologia-medica\/\">Oncologia M\u00e8dica<\/a><\/strong> es dirigeix \u200b\u200bcap a una prescripci\u00f3 personalitzada de la medicaci\u00f3, per la qual cosa sens dubte l&#8217;an\u00e0lisi de l&#8217;ADN circulant formar\u00e0 part de les consultes en el futur. <em>\u201cAquesta t\u00e8cnica, que ens permet la determinaci\u00f3 a temps real de les caracter\u00edstiques gen\u00e8tiques del tumor, sens dubte augmentar\u00e0 la superviv\u00e8ncia dels nostres pacients\u201d<\/em>, comenta el Dr.\u00a0<strong><a href=\"https:\/\/www.barnaclinic.com\/ca\/quadre-medic\/478\/javier\">Javier Garc\u00eda Corbacho<\/a><\/strong>.<\/p>\n<div id=\"estoy-interesado\" class=\"destacat-site\">\n<h4 style=\"padding-left: 15px; padding-right: 15px; text-align: left;\" align=\"CENTER\"><span style=\"color: white;\">LI POT INTERESSAR&#8230;<\/span><\/h4>\n<ul>\n<li>\n<h4 class=\"f\"><a href=\"https:\/\/www.barnaclinic.com\/ca\/diagnostic-del-cancer\/estudi-genetic-risc-cancer\/\" target=\"_blank\" rel=\"noopener noreferrer\">Estudi gen\u00e8tic per detecci\u00f3 de risc de c\u00e0ncer<\/a><\/h4>\n<\/li>\n<\/ul>\n<\/div>\n<hr \/>\n<p><small><em><a href=\"https:\/\/www.annalsofoncology.org\/article\/S0923-7534(21)02601-6\/fulltext\">92P First-results of the CLIMB360 study, a prospective molecular screening program across multiple cancer types based on circulating tumor DNA (ctDNA)<\/a><\/em><br \/>\nJ. Garcia-Corbacho, I. Victoria Ruiz, L. Angelats, S. Castillo, M. Nogu\u00e9, A. Prat<\/small><\/p>\n<hr \/>\n<div id=\"estoy-interesado\" class=\"destacat-site\">\n<h4 style=\"padding-left: 15px; padding-right: 15px;\" align=\"CENTER\">VOL M\u00c9S INFORMACI\u00d3 SOBRE BI\u00d2PSIA L\u00cdQUIDA O EST\u00c0 INTERESSAT A REALITZAR AQUESTA PROVA?<\/h4>\n<p class=\"boto\" style=\"padding-left: 30px; padding-right: 20px;\" align=\"center\"><a class=\"button\" href=\"https:\/\/www.barnaclinic.com\/ca\/solicitar-cita\/?profesional=308\" target=\"_blank&amp;\">DEMANAR CITA<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Un dels grans reptes en el tractament del c\u00e0ncer \u00e9s la seva heterogene\u00eftat. Els tumors poden presentar diferents mutacions i canviar al llarg del temps, cosa que fa que no tots els tractaments siguin efica\u00e7os o que es generin resist\u00e8ncies. Per aix\u00f2 cal fer seguiments que permetin identificar els canvis que es van produint. Tot [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":2412,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[413,434,435],"tags":[1216,499,807,1217,808,523,500],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.14 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>La bi\u00f2psia l\u00edquida demostra la seva utilitat a l&#039;an\u00e0lisi del c\u00e0ncer - Blog barnacl\u00ednic+<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.barnaclinic.com\/blog\/ca\/blog\/biopsia-liquida-analisi-del-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La bi\u00f2psia l\u00edquida demostra la seva utilitat a l&#039;an\u00e0lisi del c\u00e0ncer - Blog barnacl\u00ednic+\" \/>\n<meta property=\"og:description\" content=\"Un dels grans reptes en el tractament del c\u00e0ncer \u00e9s la seva heterogene\u00eftat. Els tumors poden presentar diferents mutacions i canviar al llarg del temps, cosa que fa que no tots els tractaments siguin efica\u00e7os o que es generin resist\u00e8ncies. Per aix\u00f2 cal fer seguiments que permetin identificar els canvis que es van produint. Tot [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.barnaclinic.com\/blog\/ca\/blog\/biopsia-liquida-analisi-del-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog barnacl\u00ednic+\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-27T15:49:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-27T15:51:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.barnaclinic.com\/blog\/wp-content\/uploads\/2021\/12\/biopsia-liquida.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"barnacl\u00ednic+\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"barnacl\u00ednic+\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.barnaclinic.com\/blog\/ca\/blog\/biopsia-liquida-analisi-del-cancer\/\",\"url\":\"https:\/\/www.barnaclinic.com\/blog\/ca\/blog\/biopsia-liquida-analisi-del-cancer\/\",\"name\":\"La bi\u00f2psia l\u00edquida demostra la seva utilitat a l'an\u00e0lisi del c\u00e0ncer - Blog barnacl\u00ednic+\",\"isPartOf\":{\"@id\":\"https:\/\/www.barnaclinic.com\/blog\/#website\"},\"datePublished\":\"2021-12-27T15:49:35+00:00\",\"dateModified\":\"2021-12-27T15:51:00+00:00\",\"author\":{\"@id\":\"https:\/\/www.barnaclinic.com\/blog\/#\/schema\/person\/54cdc3d8a00f80c3057b6dbc23ba7e07\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.barnaclinic.com\/blog\/ca\/blog\/biopsia-liquida-analisi-del-cancer\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.barnaclinic.com\/blog\/#website\",\"url\":\"https:\/\/www.barnaclinic.com\/blog\/\",\"name\":\"Blog barnacl\u00ednic+\",\"description\":\"Informaci\u00f3n y novedades sobre los servicios y profesionales de barnacl\u00ednic+, Hospital Cl\u00ednic de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.barnaclinic.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.barnaclinic.com\/blog\/#\/schema\/person\/54cdc3d8a00f80c3057b6dbc23ba7e07\",\"name\":\"barnacl\u00ednic+\",\"url\":\"https:\/\/www.barnaclinic.com\/blog\/ca\/blog\/author\/alex\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La bi\u00f2psia l\u00edquida demostra la seva utilitat a l'an\u00e0lisi del c\u00e0ncer - Blog barnacl\u00ednic+","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.barnaclinic.com\/blog\/ca\/blog\/biopsia-liquida-analisi-del-cancer\/","og_locale":"ca_ES","og_type":"article","og_title":"La bi\u00f2psia l\u00edquida demostra la seva utilitat a l'an\u00e0lisi del c\u00e0ncer - Blog barnacl\u00ednic+","og_description":"Un dels grans reptes en el tractament del c\u00e0ncer \u00e9s la seva heterogene\u00eftat. Els tumors poden presentar diferents mutacions i canviar al llarg del temps, cosa que fa que no tots els tractaments siguin efica\u00e7os o que es generin resist\u00e8ncies. Per aix\u00f2 cal fer seguiments que permetin identificar els canvis que es van produint. Tot [&hellip;]","og_url":"https:\/\/www.barnaclinic.com\/blog\/ca\/blog\/biopsia-liquida-analisi-del-cancer\/","og_site_name":"Blog barnacl\u00ednic+","article_published_time":"2021-12-27T15:49:35+00:00","article_modified_time":"2021-12-27T15:51:00+00:00","og_image":[{"width":800,"height":450,"url":"https:\/\/www.barnaclinic.com\/blog\/wp-content\/uploads\/2021\/12\/biopsia-liquida.jpg","type":"image\/jpeg"}],"author":"barnacl\u00ednic+","twitter_misc":{"Escrit per":"barnacl\u00ednic+","Temps estimat de lectura":"5 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.barnaclinic.com\/blog\/ca\/blog\/biopsia-liquida-analisi-del-cancer\/","url":"https:\/\/www.barnaclinic.com\/blog\/ca\/blog\/biopsia-liquida-analisi-del-cancer\/","name":"La bi\u00f2psia l\u00edquida demostra la seva utilitat a l'an\u00e0lisi del c\u00e0ncer - Blog barnacl\u00ednic+","isPartOf":{"@id":"https:\/\/www.barnaclinic.com\/blog\/#website"},"datePublished":"2021-12-27T15:49:35+00:00","dateModified":"2021-12-27T15:51:00+00:00","author":{"@id":"https:\/\/www.barnaclinic.com\/blog\/#\/schema\/person\/54cdc3d8a00f80c3057b6dbc23ba7e07"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.barnaclinic.com\/blog\/ca\/blog\/biopsia-liquida-analisi-del-cancer\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.barnaclinic.com\/blog\/#website","url":"https:\/\/www.barnaclinic.com\/blog\/","name":"Blog barnacl\u00ednic+","description":"Informaci\u00f3n y novedades sobre los servicios y profesionales de barnacl\u00ednic+, Hospital Cl\u00ednic de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.barnaclinic.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/www.barnaclinic.com\/blog\/#\/schema\/person\/54cdc3d8a00f80c3057b6dbc23ba7e07","name":"barnacl\u00ednic+","url":"https:\/\/www.barnaclinic.com\/blog\/ca\/blog\/author\/alex\/"}]}},"_links":{"self":[{"href":"https:\/\/www.barnaclinic.com\/blog\/ca\/wp-json\/wp\/v2\/posts\/2416"}],"collection":[{"href":"https:\/\/www.barnaclinic.com\/blog\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.barnaclinic.com\/blog\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.barnaclinic.com\/blog\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.barnaclinic.com\/blog\/ca\/wp-json\/wp\/v2\/comments?post=2416"}],"version-history":[{"count":2,"href":"https:\/\/www.barnaclinic.com\/blog\/ca\/wp-json\/wp\/v2\/posts\/2416\/revisions"}],"predecessor-version":[{"id":2421,"href":"https:\/\/www.barnaclinic.com\/blog\/ca\/wp-json\/wp\/v2\/posts\/2416\/revisions\/2421"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.barnaclinic.com\/blog\/ca\/wp-json\/wp\/v2\/media\/2412"}],"wp:attachment":[{"href":"https:\/\/www.barnaclinic.com\/blog\/ca\/wp-json\/wp\/v2\/media?parent=2416"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.barnaclinic.com\/blog\/ca\/wp-json\/wp\/v2\/categories?post=2416"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.barnaclinic.com\/blog\/ca\/wp-json\/wp\/v2\/tags?post=2416"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}